Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Brivanib alaninate

EU orphan designation number: EU/3/11/918
Active ingredient: Brivanib alaninate
Indication: Treatment of hepatocellular carcinoma
Sponsor: Bristol-Myers Squibb Pharma EEIG
Uxbridge Business Park, Sanderson Road, Uxbridge UB8 1DH, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/10/2011 Centralised Orphan - Designation EMA/OD/075/11 (2011)7896 of 27/10/2011
29/04/2013 Centralised Orphan - Removal of orphan designation from Community Register